Abstract
QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.
Original language | English |
---|---|
Pages (from-to) | 1291-1292 |
Number of pages | 2 |
Journal | Canadian Family Physician |
Volume | 56 |
Issue number | 12 |
State | Published - Dec 2010 |
Externally published | Yes |